Skip to content

Acute Effects on Stem Cell Surveillance

Clinical Trial on Rapid Effects on Stem Cell Surveillance. A Randomized Placebo-controlled Acute Cross-over Trial.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07341178
Enrollment
48
Registered
2026-01-14
Start date
2026-01-31
Completion date
2027-03-31
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stem Cell Surveillance

Keywords

Stem cells, Flow cytometry, Surveillance, Mobilization, Homing

Brief summary

The goal for this clinical trial is to compare acute immune effects of three nutraceutical ingredients and blends to a placebo.

Detailed description

The goal for this clinical trial is to compare acute immune effects of anthocyanin-rich botanical extracts and blends to a placebo. Stem cell mobilization and homing will be evaluated through monitoring of changes to the numbers of various types of stem cells in the blood circulation. The testing will show whether consuming the active test products lead to changes in stem cell numbers in circulation above the normal circadian changes for each participant. The normal circadian changes are documented on the clinic visit where placebo is consumed. Several different stem cell populations will be evaluated using flow cytometry.

Interventions

DIETARY_SUPPLEMENTAnthocyanin-rich berry extract

0.5 grams

DIETARY_SUPPLEMENTAnthocyanin-rich flower/leaf extract

0.5 grams

DIETARY_SUPPLEMENTBerry /leaf blend

0.5 grams

DIETARY_SUPPLEMENTPlacebo

Placebo (white rice-based)

Sponsors

Natural Immune Systems Inc
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Randomized, double-blinded, placebo-controlled, acute cross-over study design.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults; * Age 18-75 years (inclusive); * Veins easy to see in one or both arms (to allow for the multiple blood draws); * Willing to comply with study procedures, including: * Maintaining a consistent diet and lifestyle routine throughout the study, * Consistent habit of bland breakfasts on days of clinic visits, * Abstaining from exercising and nutritional supplements on the morning of a study visit, * Abstaining from use of coffee, tea, and soft drinks for at least one hour prior to a clinic visit, * Abstaining from music, candy, gum, computer/cell phone use, during clinic visits.

Exclusion criteria

* Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery not a problem, including previous removal of appendix and gall bladder); * Taking anti-inflammatory medications on a daily basis; * Currently experiencing intense stressful events/ life changes; * Currently in intensive athletic training (such as marathon runners); * Currently taking anxiolytic, hypnotic, or anti-depressant prescription medication; * An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying); * Unwilling to maintain a constant intake of supplements over the duration of the study; * Anxiety about having blood drawn; * Pregnant, nursing, or trying to become pregnant; * Known food allergies related to ingredients in active test product or placebo. Prescription medication will be evaluated on a case-by-case basis.

Design outcomes

Primary

MeasureTime frameDescription
Stem cell surveillanceBaseline, 1 hour, 2 hours after consumptionChanges to the number of stem cells in the blood circulation (number of cells per mL blood). Data is collected on the following types of stem cells: CD45dimCD34+CD309+, CD45dimCD34+CD309-, CD31++CD34-, CD45-CD90+.

Secondary

MeasureTime frame
Serum cytokine levelsBaseline, 1 hour, 2 hours after consumption

Countries

United States

Contacts

Primary ContactGitte S Jensen, PhD
Gitte@nislabs.com541 884 0112
Backup ContactAlex Cruickshank
Alex@nislabs.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026